
Woodland, CA, Jan. 20, 2026 (GLOBE NEWSWIRE) — Genvor, Inc. (OTC: GNVR), a biotechnology company pioneering AI-accelerated peptide technology for… Woodland, CA, Jan. 20, 2026 (GLOBE NEWSWI...
Woodland, CA, Jan. 20, 2026 (GLOBE NEWSWIRE) — Genvor, Inc. (OTC: GNVR), a biotechnology company pioneering AI-accelerated peptide technology for… Woodland, CA, Jan. 20, 2026 (GLOBE NEWSWI...